Citation Impact
1 from Science/Nature 67 standout
Citing Papers
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of H. Mesbah being referenced
Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma
2017
High impact of macroaggregated albumin‐based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with 90Y‐loaded glass microsphere radioembolization
2016
Author Peers
| Author | Surgery | Cancer Research | PFM | Hepatology | RNMI | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| H. Mesbah | 228 | 113 | 141 | 516 | 382 | 38 | 1.2k | |
| João Rodrigues | 3 | 4 | 2 | 1 | 6 | 521 | ||
| Areti Krepapa | 8 | 353 | ||||||
| Asil Avjioglu | 1 | 31 | 8 | 389 | ||||
| Umberto Peretti | 63 | 125 | 32 | 3 | 5 | 36 | 509 | |
| Jian Mao | 30 | 1 | 75 | 8 | 9 | 300 |
All Works
Login with ORCID to disown or claim papers
Loading papers...